Leukemia Clinical Trials

Showing 1881-1900 of 5,235 trials

A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC

NCT06422546

To evaluate the characteristics of genetic variationmutations at baseline and 3 weeks after oxitinib treatment in EGFRm NSCLC

Non Small Cell Lung Cancer

Beijing Cancer Prevention & Treatment Society950 participantsStarted Jan 2022

Beijing, Beijing Municipality, China

RECRUITING

Acute Right Ventricular Infarction Registry

NCT06424028

This Study aims to provide an assessment of clinical presentation, management, hospital course, and prognosis of acute right ventricular infarction presenting with or without Inferior or infero-posterior wall Myocardial Infarction and the assessment of composite adverse clinical outcome after reperfusion in-hospital and post-discharge (in 30 Days Prognosis).

Inferior Wall; Transmural Myocardial InfarctionRight Ventricular Dysfunction

National Institute of Cardiovascular Diseases, Pakistan1,000 participantsStarted Jan 2024

Karachi, Sindh, Pakistan

COMPLETEDPhase 3

Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)

NCT00406783

This study will investigate the effectiveness of desloratadine in treating subjects with allergic rhinitis (AR) who meet the criteria for intermittent allergic rhinitis.

Rhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial

Organon and Co547 participantsStarted Aug 2006

COMPLETEDPhase 1

Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer

NCT02164461

To evaluate the tolerability and safety of axalimogene filolisbac 1 x 10\^10 colony forming units (cfu) administered with prophylactic premedication in repeating 3-dose study cycles in women with persistent, metastatic, or recurrent squamous and non-squamous carcinoma, adenosquamous, or adenocarcinoma of the cervix. To evaluate tumor response and progression-free survival (PFS) by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 and immune-related Response Evaluation Criteria in Solid Tumors (irRECIST).

Effects of ImmunotherapyMetastatic/Recurrent Cervical CancerCervical Adenocarcinoma+6 more

Advaxis, Inc.12 participantsStarted Mar 2015

Augusta, Georgia, United States • Charlottesville, Virginia, United States

A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC

Acute Right Ventricular Infarction Registry

Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)

Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer

Related Searches

Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)

99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC

A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors

Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission

Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever

Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer

Motivational Interviewing in Adolescents With Epilepsy

Probiotic in Infant Growth, Allergy and Immunity Study

Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome

Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT

A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

PRECISE - Objective Measures and Observations of Physical Exposures Among Pregnant Employees in the Danish Workforce

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer

A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL